Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma. [electronic resource]
Producer: 20171004Description: 1250-1260 p. digitalISSN:- 1533-4406
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunologic Factors -- administration & dosage
- Lymphoma, Mantle-Cell -- drug therapy
- Maintenance Chemotherapy
- Male
- Middle Aged
- Proportional Hazards Models
- Rituximab -- administration & dosage
- Survival Analysis
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.